Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)
This study has been completed.
First Posted: October 21, 2010
Last Update Posted: January 25, 2016
Information provided by (Responsible Party):